Clorox (CLX) FY2021 results: revenue $7.3 billion, up 9.2% on the year
Clorox Co. (CLX) reported revenue of $7.3 billion for fiscal 2021, the year ended 30 June 2021, up 9.2% on the year before. Net income was $710 million, down 24.4%, and diluted earnings per share $5.58. The figures are the company's own, from the 10-K it filed with the SEC on 10 August 2021.
Revenue
$7.3 billion
+9.2% on the year
FY2014FY2021
Operating margin
n/a
FY2014FY2021
Net income
$710 million
-24.4% on the year
FY2014FY2021
Diluted EPS
$5.58
-24.2% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Revenue
7,341
6,721
6,214
+9.2%
Cost of revenue
4,142
3,658
3,486
+13.2%
Gross profit
3,199
3,063
2,728
+4.4%
Gross margin
43.6%
45.6%
43.9%
Research and development
149
145
136
+2.8%
Selling, general and administrative
1,004
969
856
+3.6%
Interest expense
99.0
99.0
97.0
0.0%
Pre-tax income
900
1,185
1,024
-24.1%
Income tax
181
246
204
-26.4%
Effective tax rate
20.1%
20.8%
19.9%
Net income
710
939
820
-24.4%
Net margin
9.7%
14.0%
13.2%
Diluted EPS
$5.58
$7.36
$6.32
-24.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
1,276
1,546
992
-17.5%
Capital expenditure
331
254
206
+30.3%
Free cash flow
945
1,292
786
-26.9%
Free cash flow margin
12.9%
19.2%
12.6%
Cash from investing
-452
-252
-196
Cash from financing
-1,391
-523
-815
Depreciation and amortisation
211
180
180
+17.2%
Share-based compensation
50.0
50.0
43.0
0.0%
Buybacks
905
248
661
+264.9%
Dividends paid
558
533
490
+4.7%
Dividend per share
$4.49
$4.29
$3.94
+4.7%
Diluted shares, weighted
127m
128m
130m
-0.3%
Shares outstanding at period end
123m
126m
126m
-2.7%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
411
908
559
-54.7%
Non-controlling interest
181
0.0
n/a
Debt
2,784
2,780
2,683
+0.1%
Operating lease liabilities
301
278
n/a
+8.3%
Finance lease liabilities
15.0
12.0
n/a
+25.0%
Other liabilities
2,642
2,235
1,874
+18.2%
Total liabilities and equity
6,334
6,213
5,116
+1.9%
Fixed assets
1,302
1,103
1,034
+18.0%
Goodwill
1,575
1,577
1,591
-0.1%
Intangible assets
918
894
912
+2.7%
Cash and equivalents
319
871
111
-63.4%
Receivables
604
648
631
-6.8%
Inventory
752
454
512
+65.6%
Other assets
864
666
325
+29.7%
Total assets
6,334
6,213
5,116
+1.9%
10-K for the year ended 30 June 2021, filed 10 August 2021: the filing.